Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease

Background The carnitine precursor trimethyllysine (TML) is associated with progression of atherosclerosis, possibly through a relationship with trimethylamine‐N‐oxide (TMAO). Riboflavin is a cofactor in TMAO synthesis. We examined prospective relationships of circulating TML and TMAO with acute myo...

Full description

Saved in:
Bibliographic Details
Published in:Journal of internal medicine 2020-10, Vol.288 (4), p.446-456
Main Authors: Bjørnestad, E. Ø., Olset, H., Dhar, I., Løland, K., Pedersen, E. K. R., Svingen, G. F. T., Svardal, A., Berge, R. K., Ueland, P. M., Tell, G. S., Nilsen, D. W. T., Nordrehaug, J. E., Nygaard, E., Nygård, O.
Format: Article
Language:English
Subjects:
acute myocardial infarction
Aged
Angina
Angina pectoris
Arteriosclerosis
Atherosclerosis
biomarker
Biomarkers - blood
Cardiovascular disease
Cardiovascular diseases
Carnitine
Coronary artery disease
Coronary Disease - blood
Coronary Disease - complications
epidemiology
Female
Health risks
Heart attacks
Heart Disease Risk Factors
Heart diseases
Humans
Lysine - analogs & derivatives
Lysine - blood
Male
Methylamines - blood
Middle Aged
Myocardial infarction
Myocardial Infarction - etiology
Plasma
Prospective Studies
Renal function
Riboflavin
Riboflavin - blood
Risk analysis
Risk factors
Sex ratio
Subgroups
Trimethylamine
Vitamin B
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The carnitine precursor trimethyllysine (TML) is associated with progression of atherosclerosis, possibly through a relationship with trimethylamine‐N‐oxide (TMAO). Riboflavin is a cofactor in TMAO synthesis. We examined prospective relationships of circulating TML and TMAO with acute myocardial infarction (AMI) and potential effect modifications by riboflavin status. Methods By Cox modelling, risk associations were examined amongst 4098 patients (71.8% men) with suspected stable angina pectoris. Subgroup analyses were performed according to median plasma riboflavin. Results During a median follow‐up of 4.9 years, 336 (8.2%) patients experienced an AMI. The age‐ and sex‐adjusted hazard ratio (HR) (95% CI) comparing the 4th vs. 1st TML quartile was 2.19 (1.56–3.09). Multivariable adjustment for traditional cardiovascular risk factors and indices of renal function only slightly attenuated the risk estimates [HR (95% CI) 1.79 (1.23–2.59)], which were particularly strong amongst patients with riboflavin levels above the median (Pint = 0.035). Plasma TML and TMAO were strongly correlated (rs = 0.41; P 
ISSN:0954-6820
1365-2796
DOI:10.1111/joim.13067